Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT
High-concentrated amino acid solution is used to protect the kidneys during peptide receptor radionuclide therapy (PPRT) in patients with neuroendocrine tumors (NETs). Extravasation of the solution can cause cutaneous complications. In this study, we described a 66-year-old man with metastatic medul...
Main Authors: | Chaninart Sakulpisuti, Wichana Chamroonrat, Supatporn Tepmongkol |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Tomography |
Subjects: | |
Online Access: | https://www.mdpi.com/2379-139X/8/1/29 |
Similar Items
-
Extravasation of [177Lu]Lu-DOTATOC: case report and discussion
by: Anne Kirstine Arveschoug, et al.
Published: (2020-06-01) -
177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT
by: Christophe Mazzara, et al.
Published: (2022-05-01) -
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
by: Philip E. Harris, et al.
Published: (2022-10-01) -
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
by: Baptiste Camus, et al.
Published: (2021-03-01) -
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
by: Chaninart Sakulpisuti, et al.
Published: (2022-08-01)